CVS bid for Aetna: A $66 billion gamble on slicing drug costs

NEW YORK (Reuters) – The due partnership between U.S. pharmacy user CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion gamble that insurers can expostulate down high U.S. drug prices by slicing out a middleman.

The pierce is a many costly bid to date that would capacitate a inhabitant health insurer to take behind full control of medication medicines for their business by negotiating prices with curative manufacturers and environment patron out-of-pocket costs for any drug.

CVS, one of a largest U.S. pharmacy advantages managers, has offering to buy No. 3 health insurer Aetna for some-more than $200 per share, sources pronounced on Thursday. It could take during slightest several weeks for any understanding to materialize.

If a understanding happens, it would expected vigour opposition insurers, drugmakers, curative advantages managers, and sell pharmacies to also cruise mergers or switching partners to try to keep adult with a intensity medical cost assets or boost in distinction margins.

“It’s an swap indication during this point. It’s not transparent that it’s really a improved one,” BMO Capital Markets researcher Matt Borsch said. “More converging could lead to vigour on some of a brand-name drug prices and a improved counterweight to a large pharma companies.”

For years, insurers paid drug advantages managers like CVS and Express Scripts Holdings Co to negotiate down drug prices, with both parties holding a share of any bonus by a time a medicine was paid for by consumers.

But snub over a high costs of drugs has grown as consumers have picked adult a incomparable apportionment of a add-on for drug costs and it is melancholy distinction margins all along a drug supply chain, from manufacturers to distributors, insurers and pharmacies.

UnitedHealth Group Inc and Humana Inc now have in-house pharmacy advantages businesses, and contend that it has helped them keep medical costs down.

Anthem Inc recently motionless to go down that same path. It cut ties with Express Scripts during a $3 billion authorised fight, and pronounced it would use CVS to build a possess pharmacy advantages business in a subsequent few years. That tie-up could now be during risk if CVS reaches a understanding to buy Aetna, Leerink researcher Ana Gupta said.

CVS also provides government services for Aetna opposition Cigna Corp. If CVS buys Aetna, that could revitalise Cigna’s seductiveness in shopping Humana, researcher Christine Arnold of investment bank Cowen Co pronounced in a investigate note.

Your ads will be inserted here by

Easy Plugin for AdSense.

Please go to the plugin admin page to
Paste your ad code OR
Suppress this ad slot.

Aetna progressing this year sealed a doorway on a understanding with opposition insurer Humana Inc after antitrust regulators pronounced that multiple and a opposition understanding between Anthem Inc and Cigna Corp were anti-competitive.

The pharmacy sequence Walgreens Boots Alliance could need to compare a business indication closer to CVS to try to stay competitive, Arnold pronounced in a note, and might demeanour during shopping Express Scripts.

Jefferies researcher Brian Tanquilut pronounced that Express Scripts could also be a aim for Amazon Inc that is reported to be looking to get into a pharmacy business.

SWINGING PENDULUM

Over a past decade, health insurers have diverged on a value of a pharmacy advantages business.

Anthem sole a pharmacy advantage manager to Express Scripts and outsourced roughly all of a business in 2010.

UnitedHealth took a conflicting proceed when it motionless in 2011 to move a pharmacy advantages government in house, afterwards bought an even bigger standalone advantages manager, Catamaran, in 2015.

Humana operates a possess pharmacy advantage manager and Cigna and Aetna have hybrid approaches where they conduct some tools in residence and outsource others.  

Until recently, insurers sought to enhance their distinction margins by shortening their spending on sanatorium services, regulating their distance to negotiate down what they compensate to medical providers.

But with those increase in hand, and with drug prices representing a bigger suit of altogether medical spending, they see new event in targeting a pharmacy benefits, Leerink’s Gupta said.

Another intensity captivate of a understanding for Aetna would be to gain on a flourishing series of elementary health services offering in a CVS store, from influenza shots to blood vigour checks. Reimbursing such studious caring outward of a doctor’s bureau or sanatorium could cut medical costs, Gupta said.

Reporting by Caroline Humer and Carl O’Donnell; modifying by Michele Gershberg and Meredith Mazzilli

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>